Promotion of hepatocarcinogenesis in humans and animal models
- 233 Downloads
Risk assessment based on rodent carcinogenicity data depends on the assumption of similarity between rodents and humans. While this assumption is conceivable in the case of genotoxic initiating carcinogens, considerable species differences have been observed with nongenotoxic tumor promoters. This heterogeneous group of agents increases the probability of cancer by stimulating selection and clonal expansion of cells transformed during tumor initiation. Since tumor promoters differentially affect normal tissue and preneoplastic cell clones, their action cannot be discussed without knowledge of persistent genomic and epigenetic alterations occurring during initiation and formation of preneoplastic cells. Chemical carcinogenesis, and in particular, tumor promotion, is known to be tissue specific. We focus on hepatocarcinogenesis in humans and in animal models and emphasize two different modes of action: (1) chronic cytotoxicity leading to promotion of liver carcinogenesis in both humans and animal models; (2) sustained activation of orphan receptors such as CAR, PPARα and Ah receptor leading to promotion of rodent but probably not human hepatocarcinogenesis. Further studies on the different modes of action may help to avoid overestimation of the risk of liver tumor promotion.
KeywordsHepatocarcinogenesis Tumor promoters Ethanol Phenobarbital TCDD
We apologize for having often referred to reviews to keep the number of references to a minimum.
- Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E, Herault A, Saric J, Belghiti J, Franco D, Biolac-Sage P, Laurent-Puig P, Zucman-Rossi J (2007) Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45:42–52PubMedCrossRefGoogle Scholar
- Druckrey H (1967) Quantitative aspects of chemical carcinogenesis. UICC Monogr 7:60–78Google Scholar
- IARC (1997) Polychlorinated dibenzo-para-dioxins. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol 69. IARC, Lyon, pp 33–343Google Scholar
- IARC (1999) Hormonal contraception and post-menopausal hormone therapy. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol 72. IARC, Lyon, pp 49–565Google Scholar
- IARC (2001) Phenobarbital and its sodium salt. In: IARC monographs on the evaluation of carcinogenic risks to humans, vol 79. IARC, Lyon, pp 161–288Google Scholar
- Kociba RJ, Keyes DG, Beyer JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CN, Barnard SD, Hummel RA, Humiston CG (1978) Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 46:279–303PubMedCrossRefGoogle Scholar
- Luebeck EG, Buchmann A, Stinchcombe S, Moolgavkar SH, Schwarz M (2000) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: a quantitative analysis of experimental data using a stochastic model. Toxicol Appl Pharmacol 167:63–73PubMedCrossRefGoogle Scholar
- Moolgavkar SH, Luebeck EG, Buchmann A, Bock KW (1996) Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 138:31–42PubMedCrossRefGoogle Scholar
- Schrenk D, Schäfer S, Bock KW (1994) 2,3,7,8-tetrachlorodibenzo-p-dioxin as growth modulator in mouse hepatocytes with high and low affinity Ah receptor. Carcinogenesis 17:197–202Google Scholar
- Schwarz M (1995) Tumor promotion in liver. Birkhäuser, BostonGoogle Scholar
- Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, Liu F, Huang QH, Cheng ZH, Li NG, Du JJ, Hu W, Shen KT, Lu G, Fu G, Zhong M, Xu SH, Gu WY, Huang W, Zhao XT, Hu GX, Gu JR, Chen Z, Han ZG (2001) Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 98:15089–15094PubMedCrossRefGoogle Scholar